This brief describes the case of settlements Indian drug maker Ranbaxy made with Pfizer and AstraZeneca, and Daiichi Kangyo acquisition of a controlling stake in Ranbaxy in 2008. "Hide
by Robert C. Pozen Source: Harvard Business School 2 pages. Publication Date: July 2, 2008. Prod. #: 609010-PDF-ENG